Current Advances and Future Directions for Antithrombotic Treatment Strategies

Dear Colleagues,

The last decade has seen major advances in the development and management of antithrombotic therapy, a field that is still rapidly evolving. Pivotal trials have revolutionized many aspects of antithrombotic therapy in several areas of cardiovascular disease, including atrial fibrillation, ischemic heart disease, and venous thromboembolism; however, the overarching aim remains to achieve the greatest reduction in thrombotic risk, with the minimum risk of bleeding. In the coming years, focus on high-risk patients, implementation of personalized medicine, and the inclusion of antithrombotic strategies in the context of more comprehensive and holistic treatment approaches will be some of the most intriguing challenges that we will face.

This special issue aims to collect original contributions, literature reviews (including systematic reviews and meta-analysis), viewpoints, or any other kind of contribution related to the present and future development of antithrombotic strategies in the broad field of cardiovascular diseases. Submission with a particular focus on an innovative and comprehensive approach to the topic, or current unmet needs in antithrombotic strategies, are particularly encouraged.         

Dr. Giulio Francesco Romiti
Collection Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.